Associate Professor, Medicine, Perelman School of Medicine
Nephrology
Dr. Michael D. Rudnick, MD
|
|
Give Review
Michael Rudnick works in the field of Nephrology. He attended Drexel University College of Medicine. He has 5 awards "America's Top Doctors", "Philadelphia Magazine", "CMS Meaningful Use Stage 1 Certification", "Fellow (ASNF)" and "Super Doctor". Michael D. Rudnick is a published doctor and has 43 publications published. The lastest was: 'Renal failure, hemodialysis, and nafcillin kinetics.'
Publications
- Contrast-induced nephropathy: is the picture any clearer?
- Contrast-induced nephropathy: how it develops, how to prevent it.
- Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons.
- Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
- Clinical significance and preventive strategies for contrast-induced nephropathy.
- Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insuffic...
- Acute massive hydrothorax complicating peritoneal dialysis, report of 2 cases and a review of the literature.
- Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.
- Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity.
- Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients.
- Contrast media-associated nephrotoxicity.
- Bromfenac disposition in patients with impaired kidney function.
- Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease.
- Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.
- A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
- Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy.
- Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.
- Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis.
- Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
- New approaches to the diagnosis of renovascular hypertension.
- Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy.
- Case 38-1979: Ethylene glycol poisoning.
- Lactic acidosis and the elevated anion gap (I).
- Diagnostic strategies in disorders of fluid, electrolyte and acid-base homeostasis.
- Cimetidine-induced acute renal failure.
- Correction of drug binding defects in uremia in vitro by anion exchange resin treatment.
- The kidney in health and disease: XVIII: lactic acidosis and the elevated anion gap (II).
- Human pancreatic polypeptide in chronic renal failure and cirrhosis of the liver: role of kidneys and liver in pancreatic polypeptide metabolism.
- Effects of placebo versus guanabenz on hypertensive out-patients.
- Partial purification and characterization of the drug-binding-defect inducer in uremia.
- Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.
- Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.
- Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review.
- Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
- Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
- Contrast-induced nephropathy: what are the true clinical consequences?
- The case for primary placement of tunneled hemodialysis catheters in acute kidney injury.
- Renal failure, hemodialysis, and nafcillin kinetics.
- Religiosity in a hemodialysis population and its relationship to satisfaction with medical care, satisfaction with life, and adherence.
- N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
- Acute renal failure after intravenous immunoglobulin therapy.
- Use of electrotherapy to reverse expanding cutaneous gangrene in end-stage renal disease.
Schools
State University of New York At Buffalo
Doctors Specialties
- Adolescent Medicine
- Nephrology
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (ASNF)
- Super Doctor
Education
-
University of Pennsylvania Health System -
Drexel University - Hahnemann University Hospital -
Drexel University College of Medicine
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center -
Thomas Jefferson University Hospital
Drug Facts
| NPI NUMBER | 1790719664 | |
| NPPES Provider LastName | RUDNICK | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1632.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 21.0 | |
| Percent Opioid Claims | 1.29 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790719664 |
| Last Name Of The Provider | RUDNICK |
| First Name Of The Provider | MICHAEL |
| View All |